Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken.
Watch this short video to learn why!

Benchmark: FDA’s Proposed Reclassification of Oncology Immunohistochemistry (IHC) Test Systems

Take this short benchmark to assess how much you would benefit from the course on FDA’s proposed reclassification of Immunohistochemistry (IHC) test systems for oncology therapeutic products (from Class III PMA to Class II with special controls and 510(k)).

This quick check helps you gauge your grasp of why the change is being proposed, who it affects, and what trade-offs it creates—speed vs. rigor, innovation vs. consistency, equity vs. access. It is not an exam; it’s a readiness snapshot.

After this benchmark, you will:

  • See where your understanding is strong—and where the course can close gaps on policy intent, operational impact, and risk mitigation.
  • Decide if you (or your team) need deeper guidance on special controls, labeling, PCCPs, and the PMA → 510(k) shift.
  • Know how this proposal could affect patients, clinicians, labs, and manufacturers—and your next steps.

Who benefits most from taking the full course?

  • Teams building, validating, or using oncology IHC assays (manufacturers, labs, clinical leaders).
  • Regulatory, quality, and medical affairs professionals navigating 510(k) strategy and special controls.
  • Stakeholders planning to submit informed comments during the public rulemaking process.

Time: ~5–7 minutes. No prep needed.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.

Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Hematology and Pathology Devices; Reclassification of Immunohistochemistry Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product. Document Number: 2026-23005

Buy this Course
FR-26-3326-1

About Benchmarks:

Are you ready for this regulation? Use this benchmark to find out.

Each benchmark is build directly for the federal regulation.  They reflect the learning objectives of the related course.

The benchmark is not a “trivia test” – they help you evaluate your readiness to apply the new regulation.

Contact us for more information and/or personalized benchmarks for your specific organization/industry.

Benchmark: FDA’s Proposed Reclassification of Oncology Immunohistochemistry (IHC) Test Systems

Take this short benchmark to assess how much you would benefit from the course on FDA’s proposed reclassification of Immunohistochemistry (IHC) test systems for oncology therapeutic products (from Class III PMA to Class II with special controls and 510(k)).

This quick check helps you gauge your grasp of why the change is being proposed, who it affects, and what trade-offs it creates—speed vs. rigor, innovation vs. consistency, equity vs. access. It is not an exam; it’s a readiness snapshot.

After this benchmark, you will:

  • See where your understanding is strong—and where the course can close gaps on policy intent, operational impact, and risk mitigation.
  • Decide if you (or your team) need deeper guidance on special controls, labeling, PCCPs, and the PMA → 510(k) shift.
  • Know how this proposal could affect patients, clinicians, labs, and manufacturers—and your next steps.

Who benefits most from taking the full course?

  • Teams building, validating, or using oncology IHC assays (manufacturers, labs, clinical leaders).
  • Regulatory, quality, and medical affairs professionals navigating 510(k) strategy and special controls.
  • Stakeholders planning to submit informed comments during the public rulemaking process.

Time: ~5–7 minutes. No prep needed.

NOTE: Unless otherwise indicated, all Benchmarks are free of charge!

Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Hematology and Pathology Devices; Reclassification of Immunohistochemistry Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product. Document Number: 2026-23005

Buy this Course
FR-26-3326-1

Replenish your Studio Course Advisor Unit balance here . Please contact frsales@courseavenue.com if you need to purchase more. Talk to use about an Enterprise License to see if that is right for you!

Benchmark: FDA’s Proposed Reclassification of Oncology Immunohistochemistry (IHC) Test Systems

Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Hematology and Pathology Devices; Reclassification of Immunohistochemistry Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product. Document Number: 2026-23005

Buy this Course
FR-26-3326-1

Take this short benchmark to assess how much you would benefit from the course on FDA’s proposed reclassification of Immunohistochemistry (IHC) test systems for oncology therapeutic products (from Class III PMA to Class II with special controls and 510(k)).

This quick check helps you gauge your grasp of why the change is being proposed, who it affects, and what trade-offs it creates—speed vs. rigor, innovation vs. consistency, equity vs. access. It is not an exam; it’s a readiness snapshot.

After this benchmark, you will:

  • See where your understanding is strong—and where the course can close gaps on policy intent, operational impact, and risk mitigation.
  • Decide if you (or your team) need deeper guidance on special controls, labeling, PCCPs, and the PMA → 510(k) shift.
  • Know how this proposal could affect patients, clinicians, labs, and manufacturers—and your next steps.

Who benefits most from taking the full course?

  • Teams building, validating, or using oncology IHC assays (manufacturers, labs, clinical leaders).
  • Regulatory, quality, and medical affairs professionals navigating 510(k) strategy and special controls.
  • Stakeholders planning to submit informed comments during the public rulemaking process.

Time: ~5–7 minutes. No prep needed.

Related products